Search Results - not+in+use+%3e+-nanomedicine

2 Results Sort By:
Nanopreparation for Co-Delivery of Drugs and siRNA
INV-13004 Background Overexpression of p‑glycoprotein (encoded by MDR1 gene) is often associated with multidrug-resistant cancer. This protein leads to drug resistance by the efflux of chemotherapeutic drugs from the cancerous cells. Small interfering RNA (siRNA), also known as post-transcriptional gene silencer, can suppress the expression of specific...
Published: 2/23/2026   |   Updated: 8/28/2020   |   Inventor(s): Vladimir Torchilin, Swati Biswas
Keywords(s): Delivery, Drug Delivery, Healthcare Innovation, Medical, Nanomedicine, Nanotechnology, Pharmaceutical Composition, Therapeutic
Category(s): Technology Classifications > 1. Life Science > Therapeutics, Technology Classifications > 1. Life Science > Drug Delivery, Not in use > -Pharmaceutical Composition, Not in use > -Nanotechnology, Not in use > -Nanomedicine, Not in use > -Health
Engineering Bacillus subtilis as a Versatile and Stable Platform for Production of Nanobodies
INV-20012 Background Nanobodies, are a novel class of therapeutic proteins based on single-domain antibody fragments. Due to their small size and unique structure, they have shown great potential as next generation biological drugs. Existing methods for producing these nanobodies have come with certain drawbacks. A common method for production...
Published: 4/3/2026   |   Updated: 7/3/2020   |   Inventor(s): Jiahe Li
Keywords(s): Antibody manufacturing, Drugs, Protein production, Therapeutic
Category(s): Not in use > -Nanomedicine